SWL literature
Slider

Skov-Jeppesen SM et al., 2019: [Indications and application of extracorporeal shockwave therapy] (Original article only in Danish)

Skov-Jeppesen SM, Lundrup RN, Ladegaard PBJ, Mortensen J, Sørensen MD, Lund L.
.

Abstract

Extracorporeal shockwave therapy (ESWT) is a novel treatment modality to stimulate tissue regeneration and anti-fibrosis. In this review, we summarise the use of ESWT for erectile dysfunction (ED), diabetic foot ulcers (DFU), Peyronie's disease (PD), chronic kidney disease (CKD), and scleroderma. Several randomised clinical trials demonstrate the efficacy of ESWT for vasculogenic ED and DFU, and ESWT may also relieve pain in patients with PD. ESWT is still experimental for CKD and scleroderma. In general, ESWT is associated with few and mild adverse effects.

Ugeskr Laeger. 2019 Feb 18;181(8). pii: V07180514. Danish.

0
 

Comentarios 1

Hans-Göran Tiselius en Lunes, 26 Agosto 2019 08:20

Currently no comment available.

Currently no comment available.
Invitado
Martes, 17 Septiembre 2019
STORZ MEDICAL AG
Lohstampfestrasse 8
8274 Tägerwilen
Switzerland
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05

www.storzmedical.com